Publications

← Return to the complete list of publications

CrossTalk proposal: Weighing the evidence for Class A GPCR dimers, the evidence favours dimers.

Bouvier M, Hébert TE

Département de Biochimie, Institut de Recherch en Immunologie and Cancérologie (IRIC), Université de Montréal, Montréal, Québec, Canada, H3T 1J4 michel.bouvier@umontreal.ca terence.hebert@mcgill.ca.

J. Physiol. (Lond.) 2014;592(Pt 12):2439-41.

Pubmed ID: 24931944

Follow IRIC

Logo UdeM